Overview
Multidisciplinary management of rectal cancer in young adults: facts and controversies
CTCA Rectal Cancer Dinner Meeting
Registration is closed for this activity.
This educational activity is designed to educate clinicians such as oncologists and gastroenterologists as well as physician-trainees, pharmacists, nurses and allied health professionals involved in the care and management of patients suffering from rectal cancer. In recent years, the average age of patients with rectal cancer has decreased. These younger patients require different treatment approaches. This activity is focused on sharing the various protocols for managing rectal cancer in young adults, focusing on how recommendations differ in a younger population, and emerging evidence of the effectiveness of various approaches in patients under 50.
This program is designed for oncologists, gastroenterologists, physician-trainees, pharmacists, nurses, and other allied health care professionals who are involved in the care of rectal cancer patients.
Upon completion of this educational activity, participants will be better able to:
Explain the different approaches for managing rectal cancer in young adults Identify the appropriate approach for the treatment of rectal cancer in young adults
Ocean 44
4748 N. Goldwater Blvd
Scottsdale, AZ 85251 USA
Click here to view location map
Phone: (480) 867-0044
Comment: Complimentary valet parking available on site!
4748 N. Goldwater Blvd
Scottsdale, AZ 85251 USA
Click here to view location map
Phone: (480) 867-0044
Comment: Complimentary valet parking available on site!
5:30 pm - 6:00 pm: Registration
6:00 pm - 7:30 pm: Educational Session
7:30 pm – 8:00 pm: Q&A
6:00 pm - 7:30 pm: Educational Session
7:30 pm – 8:00 pm: Q&A
Sponsored by the Academy for Continued Healthcare Learning (ACHL) and Cancer Treatment Centers of America® (CTCA)
CTCA has postponed the Rectal Cancer CME Meeting due to concerns related to the novel coronavirus. A rescheduled meeting is being planned for a later date. Anyone who has registered will be contacted with the new date and does not have to “re-register”. Thank you for your patience.
Toufic Kachaamy, MD, FASGE
Gastroenterologist & Advanced Endoscopist
Interventional Gastroenterology Program Director
Director of Endoscopy, Interventional GI and Innovation
Cancer Treatment Centers of America
Goodyear, AZ
Gastroenterologist & Advanced Endoscopist
Interventional Gastroenterology Program Director
Director of Endoscopy, Interventional GI and Innovation
Cancer Treatment Centers of America
Goodyear, AZ
Madappa Kundranda, MD, PhD, FACP
Director, Gastrointestinal Oncology Program
Deputy Chief – Division of Medical Oncology
Banner MD Anderson
Gilbert, AZ
Nitin Mishra, MBBS, MPH
Colon and Rectal Surgeon
General Surgeon
Mayo Clinic
Phoenix, AZ
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in a CME activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME activity.
The following financial relationships have been provided:
Toufic Kachaamy, MD, FASGE (Faculty)
Pending
Pending
Madappa Kundranda, MD, PhD, FACP (Faculty)
Pending
Nitin Mishra, MBBS, MPH (Faculty)
None
Pending
Nitin Mishra, MBBS, MPH (Faculty)
None
ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher.
This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
To receive credit, participants are required to participate in the live activity, complete the evaluation and submit on-site. A certificate will be emailed to participants within 6 weeks. Please be sure to check your junk/spam folders. Due to firewalls, the certificate emails sometimes go there. There is no fee to participate in the activity or for the generation of the certificate.
Inquiries may be directed to ACHL at (877) 444-8435, ext. 160.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning (ACHL) and Cancer Treatment Centers of America® (CTCA). ACHL is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The Academy for Continued Healthcare Learning designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is pending MOC Part II credit
